Chiome Bioscience Company
Chiome Bioscience is to commercialize the innovative ADLib'antibody generation technology invented at RIKEN.
Connections
Headquarters:
Tokyo, Tokyo, Japan
Funding Status:
IPO
Employee Number:
11-50
Technology:
Others
Founded Date:
2005
Industry:
PharmTech